Example: Heart Attack

Clinical Trials on Non 24 Hour Sleep Wake Disorder

Total 9 results





    • NCT03980340
      Not yet recruiting
      Breath Biomarkers for Sleep Loss and Circadian Timing
      Conditions: Shift-Work Sleep Disorder; Shift Work Type Circadian Rhythm Sleep Disorder; Sleep Disorders, Circadian Rhythm; Sleep Disorders, Intrinsic; Advanced Sleep Phase Syndrome (ASPS); Advanced Sleep Phase Syndrome; Advanced Sleep Phase; Delayed Sleep Phase; Delayed Sleep Phase Syndrome; Non-24 Hour Sleep-Wake Disorder; Irregular Sleep-Wake Syndrome
    • NCT03956745
      Not yet recruiting
      Biomarkers for Circadian Timing in Healthy Adults
      Conditions: Sleep Wake Disorders; Sleep Disorders, Circadian Rhythm; Sleep Disorders, Intrinsic; Advanced Sleep Phase Syndrome (ASPS); Advanced Sleep Phase Syndrome; Advanced Sleep Phase; Delayed Sleep Phase; Delayed Sleep Phase Syndrome; Non-24 Hour Sleep-Wake Disorder; Irregular Sleep-Wake Syndrome; Shift-Work Sleep Disorder; Shift Work Type Circadian Rhythm Sleep Disorder; Delayed Phase Sleep Syndrome
    • NCT02776215
      Unknown status
      Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents
      Conditions: Circadian Rhythm Sleep Disorders; Non-24 Hour Sleep-Wake Disorder; Autism Spectrum Disorder; Smith-Magenis Syndrome
    • NCT02130999
      Completed
      Open Label Study to Assess the Absolute Bioavailability of Tasimelteon (HETLIOZ™)
      Conditions: Non-24-Hour-Sleep-Wake Disorder
    • NCT01430754
      Completed
      Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
      Conditions: Non-24-Hour Sleep-Wake Disorder
    • NCT01429116
      Completed
      Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
      Conditions: Non-24-Hour Sleep-Wake Disorder
    • NCT01218789
      Unknown status
      Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
      Conditions: Non 24 Hour Sleep Wake Disorder
    • NCT01163032
      Completed
      Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
      Conditions: Non-24-Hour Sleep-Wake Disorder
    • NCT00972075
      Completed
      Efficacy and Safety of Circadin for Non-24 Hour Sleep-Wake Disorder in Totally Blind Subjects
      Conditions: Non-24 Hour Sleep-Wake Disorder; Blindness
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations